COOPER INC (COO)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for COO
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| COO | Director; Independent Chair of the Board | 71 | ["40+ years in healthcare industry","25 years as CEO in medical devices","experience in product development, M&A, marketing, manufacturing, and finance","MBA from Stanford University","BIE from Kettering University","served on several healthcare industry boards"] | ["Corporate Governance & Nominating"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VREX | CEO Emeritus and Senior Advisor, STERIS plc; Chair Since: 2023 | 71 | ["CEO Emeritus and Senior Advisor, STERIS plc", "CEO Emeritus and Senior Advisor, STERIS plc, a provider of infection prevention and other procedural products and services (2021\u2009\u2013\u2009present)", "President and Chief Executive Officer and Director, STERIS plc (2007\u2009\u2013\u20092021)", "Prior to joining STERIS, served as President and Chief Executive Officer of Coastal Hydraulics, Inc.; also served in various executive positions in medical device and service businesses, including Chief Executive Officer, at Hill-Rom (purchased by Baxter), a global leader in patient support systems, therapeutic products, and workflow information technology", "Service as a director and chief executive officer of a public company", "Over 40 years in the healthcare industry in various senior executive roles, including 25 years as chief executive officer", "Leadership experience in many major business functions, including product development, business development, manufacturing, finance, and marketing"] | ["M", "Audit Committee", "Nominating Committee"] | 2025 |
Biography sourced from the proxy statement filing.
Mr. Rosebrough brings experience driving significant growth and shareholder returns during his 40+ years in the healthcare industry, including 25 years as CEO in medical devices, having led organizations from startups to multi billion dollar global enterprises and functions across product development, M&A, marketing, manufacturing, and finance. Mr. Rosebrough currently serves as CEO Emeritus and Senior Advisor of STERIS plc (NYSE: STE), a global medical device business focused on infection prevention products and services. During his tenure as CEO of STERIS from 2007 to 2021, STERIS s shareholders received an 18% annualized return compared with 10% for the S&P 500, and the company s market capitalization increased from $2 billion to $20 billion. His career also includes nearly two decades at Hill-Rom (purchased by Baxter (NYSE: BAX), a global leader in patient support systems, therapeutic products, and workflow information technology where he held senior executive positions, including President and CEO of Support Systems International and President and CEO of Hill-Rom. Mr. Rosebrough has served on several healthcare industry boards, including the Association for the Advancement of Medical Instrumentation (AAMI), where he currently serves as chair; the Advanced Medical Technology Association (AdvaMed), where he was a member of the executive committee and chair of the compensation and finance committees; and the Medical Device Manufacturers Association. Mr. Rosebrough currently serves as independent chair of the board of Varex Imaging (NASDAQ: VREX), and independent member of the board of Precipart, a private company. Mr. Rosebrough holds an MBA from Stanford University, and a BIE from Kettering University.